Cox Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Cox Capital Management's AZN Position: Q3 2026 in Review
Cox Capital Management reduced its AstraZeneca (AZN) stake by 0.12% in Q3 2026, selling an estimated $4.33K and leaving 21,526 shares worth $3.48M. The position accounts for 1.95% of the portfolio, ranked #15.
Cox Capital Management first reported a position in AZN in Q1 2024 and has held it in 11 quarters since. The position peaked at $5.55M in Q4 2025. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Cox Capital Management held 21,526 shares of AstraZeneca worth $3.48M as of Q3 2026.
- Cox Capital Management sold 26 AstraZeneca shares in Q3 2026, an estimated $4.33K.
- AstraZeneca made up 1.95% of Cox Capital Management's portfolio in Q3 2026, its #15 holding.
- Cox Capital Management first reported a position in AstraZeneca in Q1 2024 and has held it in 11 quarters since.
- Cox Capital Management's AstraZeneca position peaked at $5.55M in Q4 2025.
- 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Cox Capital Management's 13F filing for Q3 2026, filed 7 Oct 2026.